MedTrace Logo

Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test

NCT04496752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-03-07

Study results available
· View outcomes & findings →

Summary

Equivalence of DCTclock-pen and DCTclock-tablet will be tested in a randomized crossover trial.

Conditions

  • Cognitive Function

Interventions

DEVICE

DCTclock

Cognitive Test

Sponsors & Collaborators

  • Linus Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Alvaro Pascual-Leone, MD · Linus Health

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2021-11-16
Completion
2021-11-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04496752 on ClinicalTrials.gov